title: Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus.
abstract: Clinically relevant doses of helper-dependent adenoviruses (HDAds) provoke the host response against capsid proteins in primates and rodents. To determine if PEGylation truly affects this, baboons and mice were given either HDAd or PEG-HDAd expressing beta-galactosidase at 5 × 10¹¹ or 3 × 10¹² virus particles per kilogram (vp/kg) by iv infusion. Serum cytokines and blood chemistries were assessed for 96 h. PEG-HDAd reduced IL-6 6-fold in mice and 3-fold in the primate. This vector reduced IL-12 by 50% in both animal models. PEGylation reduced serum transaminases by approximately 50% at each dose in the primate and the mouse. PEGylation did not alter hepatic transduction efficiency in the mouse but did reduce transduction efficiency in the liver and the spleen of primates. Unmodified and PEGylated virus suppressed hepatic CYP3A activity in both animal models. PEGylation doubled the half-life (t(½)) of the virus in the mouse and cut plasma clearance (CL) in half without affecting the half-life in primates. These results suggest that there are notable species-specific differences in the biodistribution of and response to PEG-modified vectors which may be linked to differences in binding properties to coagulation factors, receptor density and tissue architecture in the liver.
authors.affiliation: Division of Pharmaceutics, College of Pharmacy, and Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA.
authors.forename: Piyanuch
authors.initials: P
authors.lastname: Wonganan
authors.forename: Courtney C
authors.initials: CC
authors.lastname: Clemens
authors.forename: Kathy
authors.initials: K
authors.lastname: Brasky
authors.forename: Lucio
authors.initials: L
authors.lastname: Pastore
authors.forename: Maria A
authors.initials: MA
authors.lastname: Croyle
mesh_terms: D000256:Adenoviridae / Q000737:chemistry* / Q000378:metabolism*; D000818:Animals; D015139:Blotting, Southern; D015153:Blotting, Western; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D010215:Papio; D011092:Polyethylene Glycols / Q000737:chemistry*; D016133:Polymerase Chain Reaction; D014161:Transduction, Genetic
chemical_list: D011092:Polyethylene Glycols
references.citation: Mol Ther. 2008 Jul;16(7):1276-82
references.pmid: 18461056
references.citation: Hum Gene Ther. 2007 Sep;18(9):837-48
references.pmid: 17767399
references.citation: J Biol Chem. 1977 Jun 10;252(11):3582-6
references.pmid: 16907
references.citation: Curr Opin Pulm Med. 2003 Mar;9(2):111-6
references.pmid: 12574690
references.citation: Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):871-7
references.pmid: 18624676
references.citation: J Virol Methods. 2008 Mar;148(1-2):132-45
references.pmid: 18160141
references.citation: Chest. 2002 Apr;121(4):1262-8
references.pmid: 11948062
references.citation: Gene Ther. 2005 Mar;12(5):427-36
references.pmid: 15647774
references.citation: J Gen Virol. 2000 Nov;81(Pt 11):2605-2609
references.pmid: 11038370
references.citation: Curr Gene Ther. 2008 Aug;8(4):222-35
references.pmid: 18691018
references.citation: Hum Gene Ther. 2003 Nov 20;14(17):1595-604
references.pmid: 14633402
references.citation: Expert Opin Drug Deliv. 2008 Apr;5(4):371-83
references.pmid: 18426380
references.citation: Mol Ther. 2004 Aug;10(2):344-54
references.pmid: 15294181
references.citation: J Biol Chem. 1977 Jun 10;252(11):3578-81
references.pmid: 405385
references.citation: Annu Rev Biomed Eng. 2008;10:169-94
references.pmid: 18647114
references.citation: J Pharm Sci. 2008 Oct;97(10):4167-83
references.pmid: 18200508
references.citation: Mol Ther. 2001 Jan;3(1):28-35
references.pmid: 11162308
references.citation: Hum Gene Ther. 2000 Aug 10;11(12):1713-22
references.pmid: 10954905
references.citation: Br J Haematol. 2003 Dec;123(5):903-5
references.pmid: 14632782
references.citation: Hum Gene Ther. 2002 Jan 1;13(1):143-54
references.pmid: 11779418
references.citation: Hum Gene Ther. 2008 Dec;19(12):1369-82
references.pmid: 18778197
references.citation: Int J Pharm. 2008 Apr 16;354(1-2):9-15
references.pmid: 17640834
references.citation: Curr Drug Saf. 2008 Jan;3(1):46-53
references.pmid: 18690980
references.citation: Pharmacogenet Genomics. 2010 Mar;20(3):167-78
references.pmid: 20147837
references.citation: Acad Emerg Med. 2008 Sep;15(9):795-9
references.pmid: 19244629
references.citation: Crit Rev Ther Drug Carrier Syst. 2008;25(5):403-47
references.pmid: 19062633
references.citation: N Engl J Med. 2001 May 17;344(20):1498-503
references.pmid: 11357152
references.citation: Gene Ther. 2005 Apr;12(7):579-87
references.pmid: 15647765
references.citation: Blood. 2007 Apr 1;109(7):2832-9
references.pmid: 17148587
references.citation: Curr Drug Metab. 2008 May;9(4):310-22
references.pmid: 18473749
references.citation: Virology. 1968 Sep;36(1):115-25
references.pmid: 5669982
references.citation: Gene Ther. 2003 Jun;10(12):1012-7
references.pmid: 12776158
references.citation: Methods Enzymol. 1978;52:109-17
references.pmid: 672621
references.citation: Hum Gene Ther. 2006 Apr;17(4):391-404
references.pmid: 16610927
references.citation: Pharmacogenet Genomics. 2008 Jan;18(1):53-66
references.pmid: 18216722
references.citation: Mol Genet Metab. 2003 Sep-Oct;80(1-2):148-58
references.pmid: 14567964
references.citation: Biotechnol Bioeng. 2005 Oct 5;92(1):24-34
references.pmid: 15937953
references.citation: Hum Gene Ther. 2003 May 20;14(8):777-87
references.pmid: 12804140
references.citation: Support Care Cancer. 2007 Mar;15(3):251-7
references.pmid: 17139496
references.citation: Hum Gene Ther. 2004 Jan;15(1):35-46
references.pmid: 14965376
references.citation: Virus Res. 2008 Mar;132(1-2):1-14
references.pmid: 18036698
references.citation: Pharm Dev Technol. 1998 Aug;3(3):373-83
references.pmid: 9742558
references.citation: Cancer Treat Rep. 1979 Jun;63(6):1127-32
references.pmid: 466651
references.citation: Br J Pharmacol. 2009 May;157(2):153-65
references.pmid: 18776913
references.citation: Int Rev Cytol. 1982;80:27-61
references.pmid: 6295978
references.citation: J Control Release. 2005 Nov 2;108(1):161-77
references.pmid: 16125817
references.citation: Am J Hum Genet. 1997 Sep;61(3):489-93
references.pmid: 9326312
references.citation: Mol Ther. 2007 Aug;15(8):1410-6
references.pmid: 17505469
references.citation: Expert Opin Drug Metab Toxicol. 2005 Dec;1(4):629-40
references.pmid: 16863429
references.citation: J Gene Med. 2006 May;8(5):566-76
references.pmid: 16508909
references.citation: Viruses. 2010 Feb;2(2):468-502
references.pmid: 21994645
references.citation: Hum Gene Ther. 2004 May;15(5):433-43
references.pmid: 15144574
references.citation: Methods Enzymol. 2002;346:177-98
references.pmid: 11883068
references.citation: Immunol Rev. 2001 Oct;183:127-40
references.pmid: 11782253
references.citation: Circulation. 2001 Mar 6;103(9):1274-81
references.pmid: 11238273
references.citation: BioDrugs. 2008;22(5):315-29
references.pmid: 18778113
references.citation: Drug Metab Dispos. 2008 Feb;36(2):205-16
references.pmid: 18218849
references.citation: Cell. 2008 Feb 8;132(3):397-409
references.pmid: 18267072
references.citation: Mol Ther. 2001 May;3(5 Pt 1):708-22
references.pmid: 11356076
references.citation: Mol Ther. 2005 Jan;11(1):66-79
references.pmid: 15585407
references.citation: Hum Gene Ther. 2002 Oct 10;13(15):1887-900
references.pmid: 12396620
references.citation: Virol J. 2008 Sep 30;5:111
references.pmid: 18826641
references.citation: J Pharmacol Exp Ther. 2005 Feb;312(2):492-501
references.pmid: 15496614
references.citation: Mol Ther. 2008 Jan;16(1):16-29
references.pmid: 17912234
references.citation: Am J Physiol. 1979 May;236(5):H775-9
references.pmid: 443399
references.citation: J Allergy Clin Immunol. 2006 Aug;118(2):295-302; quiz 303-4
references.pmid: 16890750
references.citation: P T. 2008 Nov;33(11):642-51
references.pmid: 19750060
references.citation: Gene Ther. 2008 Apr;15(8):553-60
references.pmid: 18288209
references.citation: Hum Gene Ther. 1999 Oct 10;10(15):2515-26
references.pmid: 10543616
references.citation: Methods Mol Biol. 2008;433:55-78
references.pmid: 18679617
references.citation: J Virol. 2001 May;75(10):4792-801
references.pmid: 11312351
references.citation: ILAR J. 2008;49(2):220-55
references.pmid: 18323583
references.citation: Anal Biochem. 1984 Apr;138(1):57-65
references.pmid: 6731853
references.citation: Br J Pharmacol. 2008 Aug;154(7):1382-99
references.pmid: 18604233
references.citation: Hum Gene Ther. 1999 May 20;10(8):1349-58
references.pmid: 10365665
references.citation: Curr Gene Ther. 2007 Oct;7(5):297-305
references.pmid: 17979676
references.citation: J Virol. 2004 Jan;78(2):912-21
references.pmid: 14694122
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5483-8
references.pmid: 18391209
references.citation: Cancer Gene Ther. 2002 Jul;9(7):553-66
references.pmid: 12082455
references.citation: Adv Drug Deliv Rev. 2003 Sep 26;55(10):1293-302
references.pmid: 14499708